Every semaglutide program
Semaglutide Providers Online: The Complete 2026 List
All 21 semaglutide programs we track — compounded from $133/mo, capped-dose outliers labeled, brand at $349 flat ($149 oral intro).
The complete semaglutide field in one place: every compounded program with a verifiable price (ranked all-in at the standing rate), the capped and microdose tiers labeled as the different products they are, and the brand channel that now competes on price instead of just legitimacy. Semaglutide is the budget molecule of the class — its floor undercuts tirzepatide's by ~$80/month — and the evidence-backed one, holding the class's cardiovascular-outcomes indication (SELECT: 20% MACE reduction) and its only pill. Deep dives: the prose ranking, the science hub, and every program's full review below.
Semaglutide runs $133 a month all-in. Not available in California; month-to-month runs about $167–$199. No membership fee.
Semaglutide runs $146 a month all-in. No membership fee.
Semaglutide runs $149 a month all-in. No membership fee. Evidence: no price published.
Semaglutide runs $165 a month all-in at the standing rate ($145 on intro/plan terms). $145 requires the 12-month plan; $165 month-to-month ($149/$147 at 3/6 months); microdose $129→$110 by term; sublingual ODT $199→$165. No membership fee.
Semaglutide runs $175 a month all-in. No membership fee. Evidence: third-party-reported.
Semaglutide runs $178 a month all-in.
Semaglutide runs $179 a month all-in at the standing rate ($149 on intro/plan terms). No membership fee. Evidence: third-party-reported.
Semaglutide runs $198 a month all-in.
Semaglutide runs $199 a month all-in at the standing rate ($174 on intro/plan terms).
Semaglutide runs $199 a month all-in. No membership fee.
Semaglutide runs $224 a month all-in at the standing rate ($149 on intro/plan terms).
Semaglutide runs $249 a month all-in at the standing rate ($212 on intro/plan terms). No membership fee.
Semaglutide runs $249 a month all-in at the standing rate ($175 on intro/plan terms). No membership fee.
Semaglutide runs $289 a month all-in at the standing rate ($169 on intro/plan terms). No membership fee. Evidence: third-party-reported.
Semaglutide runs $289 a month all-in. No membership fee.
Semaglutide runs $299 a month all-in at the standing rate ($179 on intro/plan terms). No membership fee.
Semaglutide runs $299 a month all-in. No membership fee. Evidence: third-party-reported.
Semaglutide runs $299 a month all-in at the standing rate ($179 on intro/plan terms). No membership fee.
Semaglutide runs $348 a month all-in. Evidence: third-party-reported.
The labeled outlier: $199/month for compounded semaglutide capped at 0.6 mg — a quarter of the STEP-trial dose, billed quarterly, pharmacy named (Tailor Made). Excluded from the full-dose ranking because it's a different product tier, listed because you'll see it advertised as if it weren't.
The brand channel: Wegovy $349 flat at every standard injectable dose, $199 × 2 starter offer, oral tablet at $149 intro, savings-card pickup at 70,000+ pharmacies — FDA-approved product at prices inside the compounded range's upper half.
Semaglutide-specific fine print
Format changes the price at several programs (Henry's injection $149 vs sublingual $179; MEDVi's tiers), state lines change it at others (Oak excludes CA; bmiMD and MEDVi bill $379.99 in CA/NC), and term framing changes it almost everywhere (ShedRx $175/$199/$249 by commitment; Enhance $212–$249; TrimRx's $179 first month → $299). The one-line defense: get the standing, full-dose, your-state, all-in figure in writing — four adjectives that dissolve 90% of this market's framing.
The market, in four load-bearing numbers
The floor and the ceiling: NexLife’s $215 flat all-in against LifeMD’s $597 split-billed — $4,584 a year apart for the identical 10 mg basis, which is the whole argument for normalization. Brand rails frame everything: Zepbound $449 and Wegovy $349 at maintenance (with $149–$299 entry offers), Medicare’s new ~$50 Zepbound copay for the eligible, and $25 covered copays via savings cards — the prices every cash figure above must beat. Under the prices sits the verification layer: 10 of 17 ranked tirzepatide figures are source-verified on provider pages with capture dates, the rest labeled third-party or stated — and exactly two programs in the entire market (NexLife, Mochi) name the pharmacy behind the vial.
How to use this page without getting played
Read rank position last: the sentence under each name carries the conditions (term, membership, dose structure) that decide whether the number applies to you at all. Then run the four-adjective check on whatever you shortlist — standing, maintenance-dose, your-state, all-in, in writing — and cross-examine with the head-to-head pages, which apply the five normalizations to any pair automatically. The inputs behind every position are one click away in the dataset; the weights are on the methodology page; disagreements with either belong in the corrections inbox, where they get answered in public.
Frequently asked
How many online semaglutide providers are there?
We track 19 with verified full-dose compounded pricing ($133–$348/mo all-in), plus capped/microdose tiers and the brand channel at $349 flat.
What's a fair price for compounded semaglutide?
Injection, sublingual, or the pill?
Weekly injection has the deepest evidence (STEP/SELECT); sublingual compounded formats trade convenience for thinner data; the new oral Wegovy tablet is FDA-approved with ~15% trial loss and strict empty-stomach rules. Format is a clinician conversation — price differences are on this page.